Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Working Capital Changes (2016 - 2025)

Capricor Therapeutics (CAPR) has 14 years of Other Working Capital Changes data on record, last reported at $966329.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 108.76% year-over-year to $966329.0; the TTM value through Sep 2025 reached $12.4 million, up 216.64%, while the annual FY2024 figure was $458653.0, 504.41% up from the prior year.
  • Other Working Capital Changes reached $966329.0 in Q3 2025 per CAPR's latest filing, up from -$111096.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $30.0 million in Q1 2022 and bottomed at -$30.5 million in Q2 2022.
  • Average Other Working Capital Changes over 5 years is $78106.4, with a median of $26500.0 recorded in 2021.
  • The widest YoY moves for Other Working Capital Changes: up 113107.55% in 2022, down 31780.78% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at $148728.0 in 2021, then soared by 287.42% to $576208.0 in 2022, then dropped by 6.74% to $537359.0 in 2023, then skyrocketed by 2058.45% to $11.6 million in 2024, then tumbled by 91.67% to $966329.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $966329.0 in Q3 2025, -$111096.0 in Q2 2025, and -$87147.0 in Q1 2025.